Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
24 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Tolero Pharmaceuticals, Inc. (Tolero) is a clinical-stage biopharmaceutical company that discovers and develops therapeutic inhibitors. The companys lead candidate, Alvocidib, is a cyclin-dependent kinase (CDK) inhibitor with selective activity against CDK9 and also CDK4/6. Alvocidib is primarily being developed for acute myeloid leukemia. It is also indicated for multiple types of cancer including both solid tumors and hematological malignancies. Toleros preclinical stage products include TP-1287 (Oral CDK9 Inhibitor), TP-0903 (AXL Kinase Inhibitor) and TP-0184 (BMPR Signaling Inhibitor).

Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary o

  
Source:
Document ID
GDPH408636D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Tolero Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 201691
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Tolero Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1110
  Asset Purchase111
    Tolero Pharma Acquires Drug Development Assets From Astex Pharma112
  Venture Financing131
    Tolero Pharma Raises USD8.2 Million in Second Tranche of Series B Financing131
    Tolero Pharma Raises USD14.2 Million in Series B Venture Financing141
    Tolero Pharma Raises US$3.33 Million In Venture Financing151
  Partnerships161
    Eutropics Enters Into Co-Development Agreement With Tolero Pharma161
  Licensing Agreements171
    Tolero Pharma Enters Into Licensing Agreement With Sanofi For Alvocidib172
    MannKind Enters Into Licensing Agreement With Tolero Pharma For Bruton s Tyrosine Kinase Inhibitors192
Tolero Pharmaceuticals, Inc. - Key Competitors211
Key Employees221
Locations And Subsidiaries231
  Head Office231
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tolero-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23257>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Tolero Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tolero-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23257>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research